By vgreene, 5 February, 2021 F U q2 6wk while gaining control q1 6mo to monitor control q3mo if step down tx anticipated
By vgreene, 5 February, 2021 Educate sx meds inhaler technique environment control 6 comorbidity7 mgmt
By vgreene, 5 February, 2021 Written action plan based on sx or peak flow consider daily peak flow monitoring
By vgreene, 5 February, 2021 Alternatives w prn SABA 3 med dose ICS Step 3 med dose ICS LABA Step 4 med dose ICS LTRA Step 4 med dose ICS theophylline Step 4
By vgreene, 5 February, 2021 May use FeNO as part of monitoring w hx clinical findings spirometry in pts w persistent allergic asthma
By vgreene, 5 February, 2021 F U q2 6wk while gaining control q1 6mo to monitor control q3mo if step down tx anticipated consider asthma specialist consult
By vgreene, 5 February, 2021 Written action plan based on sx or peak flow consider daily peak flow monitoring
By vgreene, 5 February, 2021 Alternatives w prn SABA 3 med dose ICS low dose ICS LABA low dose ICS LTRA low dose ICS theophylline
By vgreene, 5 February, 2021 Use single inhaler maintenance reliever tx SMART low dose ICS formoterol daily prn sx max 8 puffs day 36 mcg formoterol
